You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BLTE Sale Disclosure
Scholl Hendrik Peter · SEC Form 4 · Filed Jun 22, 2026
Sale
Calculated transaction value
$706.96K
Scholl Hendrik Peter Chief Medical Officer
BLTE
Belite Bio, Inc
BLTE
Transaction date
Jun 18, 2026
Public filing date
Jun 22, 2026
Filing lag
Filed 4 days later
BLTE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- American depositary share
- Quantity / price
- 4,861 shares @ $145.43
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-276615
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$1.45M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Belite Bio, Inc BLTE | Sale | Jun 18, 2026 | $13.81K |
| Belite Bio, Inc BLTE | Sale | Jun 18, 2026 | $542.19K |
| Belite Bio, Inc BLTE | Sale | Jun 18, 2026 | $14.12K |
| Belite Bio, Inc BLTE Current | Sale | Jun 18, 2026 | $706.96K |
| Belite Bio, Inc BLTE | Sale | Jun 18, 2026 | $175.35K |